Compound index

Amylin Receptor Agonists

Cagrilintide

Late-stage human trialsInvestigational

Last reviewed: 2026-11-19

History

Novo Nordisk developed cagrilintide; early randomized human results were published in 2021.

Key sources

Primary-reference and editorial check: November 19, 2026. Not an exhaustive clinical review; exact formulations and populations matter.

Related glossary terms